EVO: Evotec AG Market Price to Net Income Ratio

The new CEO of Evotec SE (EVO) aims to stabilize margins and restore shareholder confidence, while the current P/E ratio on GURU.Markets clearly visualizes this process, where -2.80 captures the value of this parameter. The business foundation is based on partner risk-sharing and royalties with pharma behemoths, while research reliability is ensured by costly temperature control during the transport of biomaterials.

EVO Evotec: Price to Earnings Ratio in the range 09/25/2023 - 11/12/2026

Analytical breakdowns for Evotec SE

- share price and expert price forecast:

Price Performance Chart evotec.com|EVO - Consensus Target

- market capitalization information:

Market Value Evotec SE|EVO - Enterprise Value

- book capitalization indicators:

Net Asset Value per Share Evotec|EVO - Company Book Value|Market Capitalization to Book Value evotec.com|EVO - Cumulative Company Assets

- debt and solvency information:

- business earnings and investment ratios data:

EVO - Net Income|Future Net Profit Evotec SE|EVO - P/E Multiple|Projected Price to Earnings Ratio Evotec AG|EVO - PEG Multiple|Enterprise Value to EBITDA Ratio Evotec SE|EVO - Operating profit before deduction of amortization|Earnings per share for the trailing year Evotec|EVO - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months evotec.com|EVO - Earnings growth in current year|Expected net earnings per share growth next year Evotec SE

Summary company analysis:EVO (evotec.com)

The P/E ratio determines the market value of a single unit of profit, allowing an investor to assess the investment payback period and the extent of the asset's overvaluation. Analyzing the P/E ratio trend reveals how the high valuation of Evotec SE (EVO) is justified by the uniqueness of its biotechnological ecosystem, which creates a critical dependency of pharma behemoths on integrated IT research and complex laboratory cycles.

Competing companies